High insulin prices spur a U.S. federal lawsuit against three pharmacy benefit managers
Three companies that process about 80% of prescriptions in the United States—Caremark, Express Scripts and OptumRx—have engaged in anticompetitive practices that spur price increases, the Federal Trade Commission alleged in a lawsuit filed Friday.